Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
Mohini Ranganathan, Jose Cortes-Briones, Rajiv Radhakrishnan, et al.
Biological Psychiatry (2015) Vol. 79, Iss. 12, pp. 997-1005
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
Justine Y. Hansen, Golia Shafiei, Ross D. Markello, et al.
Nature Neuroscience (2022) Vol. 25, Iss. 11, pp. 1569-1581
Open Access | Times Cited: 405
Local molecular and global connectomic contributions to cross-disorder cortical abnormalities
Justine Y. Hansen, Golia Shafiei, Jacob W. Vogel, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis
Sagnik Bhattacharyya, Robin Wilson, Elizabeth Appiah‐Kusi, et al.
JAMA Psychiatry (2018) Vol. 75, Iss. 11, pp. 1107-1107
Open Access | Times Cited: 131
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 104
Sex difference in brain CB1 receptor availability in man
Heikki Laurikainen, Lauri Tuominen, Maria Tikka, et al.
NeuroImage (2018) Vol. 184, pp. 834-842
Open Access | Times Cited: 85
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
Deepak Cyril D’Souza, Marta Di Forti, Suhas Ganesh, et al.
The World Journal of Biological Psychiatry (2022) Vol. 23, Iss. 10, pp. 719-742
Closed Access | Times Cited: 63
Integrating brainstem and cortical functional architectures
Justine Y. Hansen, Simone Cauzzo, Kavita Singh, et al.
Nature Neuroscience (2024)
Open Access | Times Cited: 10
Contributions of network structure, chemoarchitecture and diagnostic categories to transitions between cognitive topographies
Andrea I. Luppi, S. Parker Singleton, Justine Y. Hansen, et al.
Nature Biomedical Engineering (2024) Vol. 8, Iss. 9, pp. 1142-1161
Open Access | Times Cited: 9
The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
Albert Batalla, Hella Janssen, Shiral S. Gangadin, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 7, pp. 1058-1058
Open Access | Times Cited: 71
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia
Claudio D’Addario, Vincenzo Micale, Martina Di Bartolomeo, et al.
Schizophrenia Research (2017) Vol. 188, pp. 132-140
Closed Access | Times Cited: 64
Cannabidiol attenuates insular dysfunction during motivational salience processing in subjects at clinical high risk for psychosis
Robin Wilson, Matthijs G. Bossong, Elizabeth Appiah‐Kusi, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 59
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis
Faith Borgan, Heikki Laurikainen, Mattia Veronese, et al.
JAMA Psychiatry (2019) Vol. 76, Iss. 10, pp. 1074-1074
Open Access | Times Cited: 57
Endocannabinoid system in psychotic and mood disorders, a review of human studies
Ranjini Garani Ramesh, Jeremy J. Watts, Romina Mizrahi
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110096-110096
Open Access | Times Cited: 51
Positron Emission Tomography Imaging of the Endocannabinoid System: Opportunities and Challenges in Radiotracer Development
Lu Hou, Jian Rong, Ahmed Haider, et al.
Journal of Medicinal Chemistry (2020) Vol. 64, Iss. 1, pp. 123-149
Open Access | Times Cited: 51
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
Justine Y. Hansen, Golia Shafiei, Ross D. Markello, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 41
Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 6, pp. 3485-3503
Closed Access | Times Cited: 30
Mapping neurotransmitter systems to the structural and functional organization of the human neocortex
Justine Y. Hansen, Golia Shafiei, Ross D. Markello, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 28
Cannabinoids as hippocampal network administrators
Carl R. Lupica, Yuhan Hu, Orrin Devinsky, et al.
Neuropharmacology (2017) Vol. 124, pp. 25-37
Closed Access | Times Cited: 51
Systems biology approaches to study lipidomes in health and disease
Marina Amaral Alves, Santosh Lamichhane, Alex M. Dickens, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1866, Iss. 2, pp. 158857-158857
Open Access | Times Cited: 47
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 33
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Daniela Navarro, Ani Gasparyan, Francisco Navarrete, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4764-4764
Open Access | Times Cited: 24
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
F. Markus Leweke, Juliane K. Mueller, Bettina Lange, et al.
CNS Drugs (2018) Vol. 32, Iss. 7, pp. 605-619
Closed Access | Times Cited: 45
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders
Musa Sami, Sagnik Bhattacharyya
Journal of Psychopharmacology (2018) Vol. 32, Iss. 8, pp. 825-849
Open Access | Times Cited: 44
Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies
Matthew E. Sloan, Caroline W. Grant, Joshua L. Gowin, et al.
Acta Pharmacologica Sinica (2018) Vol. 40, Iss. 3, pp. 342-350
Open Access | Times Cited: 42
A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis
Maya R. Jacobson, Jeremy J. Watts, Isabelle Boileau, et al.
European Neuropsychopharmacology (2019) Vol. 29, Iss. 3, pp. 330-348
Closed Access | Times Cited: 39
Page 1 - Next Page

Scroll to top